Community Pharmacy—Based Medication Assessment Program for Asthma and Chronic Obstructive Pulmonary Disease

Abstract

Get full access to this article

View all access options for this article.

References

National Asthma Education and Prevention Program Expert Panel Report 3: guidelines for the diagnosis and management of asthma. Summary Report 2007. J Allergy Clin Immunol 2007;120(5 suppl):S94–S138.

Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease, 2010. Available: www.goldcopd.org/Guidelines/guideline-2010-gold-report.html (accessed January 5, 2010).

Benavides

Rodriguez

Maniscalco-Feichtl

. Pharmacist involvement in improving asthma outcomes in various healthcare settings: 1997 to present. Ann Pharmacother 2009;43:85–97.

Weinberger

Murray

Marrero

Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial. JAMA 2002;288:1594–602.

Kritikos

Reddel

Bosnic-Anticevich

. Pharmacists' perceptions of their role in asthma management and barriers to the provision of asthma services. Int J Pharm Pract 2010;18:209–16.

René-Henri

Khamla

Nadaira

Community pharmacists' interventions in asthma care: a descriptive study. Ann Pharmacother 2009;43:104–11.